Clincosm LogoSign in Get a demo

safety

Showing 51 - 75 of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesenchymal Stromal Cells, Cornea, Safety Trial in Chicago (Allogeneic MSC)

Recruiting
  • Mesenchymal Stromal Cells
  • +3 more
  • Allogeneic MSC
  • Chicago, Illinois
    University of Illinois, Department of Ophthalmology and Visual S
Apr 19, 2022

Healthy Volunteers, Safety Trial in Copenhagen (SoftOx Inhaled Solution (SIS), Placebo)

Completed
  • Healthy Volunteers
  • Safety
  • SoftOx Inhaled Solution (SIS)
  • Placebo
  • Copenhagen, Denmark
    DanTrials ApS
Apr 18, 2022

Efficacy, Safety Trial (PD-L1 inhibitor)

Not yet recruiting
  • Efficacy
  • Safety
  • PD-L1 inhibitor
  • (no location specified)
Apr 6, 2022

pCR Rate, BCT Rate, Safety Trial in Linyi, Shanghai (Metformin, Docetaxel, Epirubicin)

Terminated
  • pCR Rate
  • +2 more
  • Linyi, Shandong, China
  • +1 more
Mar 28, 2022

COVID-19, Pharmacokinetics, Safety Trial in Pittsburgh (Q-Griffithsin, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Pittsburgh, Pennsylvania
    Ingrid Macio
Mar 31, 2022

Safety, Immunogenicity, Vaccine, COVID-19 Vaccines Trial in Beijing (Vaccine)

Recruiting
  • Safety
  • +4 more
  • Vaccine
  • Beijing, China
  • +2 more
Mar 24, 2022

ECG, Pharmacokinetics, Safety Trial in Worldwide (Gemtuzumab Ozogamicin)

Completed
Has Results
  • ECG
  • +2 more
  • Gemtuzumab Ozogamicin
  • Augusta, Georgia
  • +23 more
Feb 28, 2022

Safety, Acceptability Trial in Pittsburgh (High Eudragit® Content Vaginal Film, Low Eudragit® Content Vaginal Film)

Completed
Has Results
  • Safety
  • Acceptability
  • High Eudragit® Content Vaginal Film
  • Low Eudragit® Content Vaginal Film
  • Pittsburgh, Pennsylvania
    University of Pittsburgh, Magee Womens Hospital
Feb 2, 2022

Tislelizumab, Safety, Biomarker Trial in Guangzhou, Jiangmen (Tislelizumab 200 mg, Carboplatin AUC 5, pemetrexed 500mg/m2)

Recruiting
  • Tislelizumab
  • +3 more
  • Tislelizumab 200 mg
  • +4 more
  • Guangzhou, Guangdong, China
  • +3 more
Feb 8, 2022

Safety, Tolerability Trial in Leeds (AM1476 - Placebo)

Completed
  • Safety
  • Tolerability
  • AM1476 - Placebo
  • Leeds, United Kingdom
    Covance Clinical Research Unit
Feb 15, 2022

Healthy Volunteers, Tolerability, Safety Trial in Uppsala (Probiotic, Placebo)

Completed
  • Healthy Volunteers
  • +2 more
  • Probiotic
  • Placebo
  • Uppsala, Sweden
  • +1 more
Jan 28, 2022

Endoscopic Surgical Procedure, Safety, Training Trial in Spain (Gastroenterostomy)

Not yet recruiting
  • Endoscopic Surgical Procedure
  • +2 more
  • Gastroenterostomy
  • Badalona, Barcelona, Catalonia, Spain
  • +5 more
Jan 30, 2022

Safety, Efficacy, Self Trial in Spain (Stem Cell Therapy)

Recruiting
  • Safety
  • Efficacy, Self
  • Stem Cell Therapy
  • Elche, Alicante, Spain
  • +3 more
Jan 13, 2022

Immunogenicity, Safety Trial in Bandung (Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered))

Completed
  • Immunogenicity
  • Safety
  • Recombinant Hepatitis B + DTP-HB-Hib
  • Hep B + Pentabio (registered)
  • Bandung, West Java, Indonesia
  • +2 more
Jan 13, 2022

Safety, Tolerability, Ocular Surface Trial in Guadalajara (Bepotastine Besilate)

Completed
  • Safety
  • +3 more
  • Bepotastine Besilate
  • Guadalajara, Jalisco, Mexico
    Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021

Patients With Advanced Refractory Solid Tumors

Not yet recruiting
  • Feasibility
  • +3 more
  • Targeted therapy
  • (no location specified)
Dec 14, 2021

Safety, Vaccine Reaction, Vaccine Adverse Reaction Trial (S.opt.FL COVID-19 pDNA vaccine)

Not yet recruiting
  • Safety
  • +3 more
  • S.opt.FL COVID-19 pDNA vaccine
  • (no location specified)
Dec 22, 2021

Bioequivalence, Safety Trial in Mount-Royal (Fingolimod 0.5 mg capsules- Test drug)

Completed
  • Bioequivalence
  • Safety
  • Fingolimod 0.5 mg capsules- Test drug
  • Mount-Royal, Quebec, Canada
    Algorithme Pharma Inc.
Dec 6, 2021

Samsca PMS in ADPKD Patients

Recruiting
  • Safety
  • Ulsan, Gyeongsangnam-do, Korea, Republic of
    Kim Med Clinic
Dec 16, 2021

Safety, SARS-CoV2 Infection, Ivermectin Poisoning Trial in Bangkok (Ivermectin, Placebo)

Completed
  • Safety
  • +3 more
  • Bangkok, Thailand
    Thananda Trakarnvanich
Dec 14, 2021

Subjects in Need of a Human Milk Fortifier (HMF), Growth, Tolerance Trial in Worldwide (Test product, Control product)

Active, not recruiting
  • Subjects in Need of a Human Milk Fortifier (HMF)
  • +3 more
  • Test product
  • Control product
  • Lyon, France
  • +14 more
Dec 7, 2021

DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using

Recruiting
  • Ovarian Neoplasms
  • +8 more
    • Montreal, Quebec, Canada
    • +1 more
    Oct 14, 2021

    Analgesia in ÖAMTC Helicopter Emergency Service in Austria

    Completed
    • Field Physician Care
    • +7 more
    • analgesics
    • hypnotics
    • Innsbruck, Austria
      General and Surgical Critical Care Medicine, Medical University
    Sep 7, 2021

    Malaria Vaccine Pilot Evaluation

    Active, not recruiting
    • Malaria,Falciparum
    • +3 more
    • Feasibility survey
    • +2 more
    • Kintampo, Ghana
    • +2 more
    Aug 6, 2021

    Keloid, Autologus Adipose Derived Stem Cells, Feasibility Trial in Kampala (Autologous adipose derived stem cells)

    Completed
    • Keloid
    • +3 more
    • Autologous adipose derived stem cells
    • Kampala, Uganda
      Department of Surgery, Makerere University College of Health Sci
    Jun 16, 2021